These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Intermittent chemotherapy of pulmonary tuberculosis using rifampicin and isoniazed for primary treatment: the influence of various factors on the frequency off side-effects]. Aubert MF, Beaucournu JC. Ann Parasitol Hum Comp; 1976; 51(1):143-56. PubMed ID: 937975 [Abstract] [Full Text] [Related]
3. Intermittent chemotherapy of pulmonary tuberculosis using rifampicin and isoniazid for primary treatment: the influence of various factors on the frequency of side-effects. Eule H, Werner E, Winsel K, Iwainsky H. Tubercle; 1974 Mar; 55(1):81-9. PubMed ID: 4620295 [No Abstract] [Full Text] [Related]
6. On the pharmacokinetics of rifampicin I: Influence of dosage and duration of treatment with intermittent administration. Iwainsky H, Winsel K, Werner E, Eule H. Scand J Respir Dis; 1974 Mar; 55(4):229-36. PubMed ID: 4438983 [No Abstract] [Full Text] [Related]
8. Controlled therapeutic trial with the combination rifampicin-isoniazid given for six months to previously untreated patients with pulmonary tuberculosis. Dubra F. Bull Int Union Tuberc; 1972 Feb; 47():37-40. PubMed ID: 4562016 [No Abstract] [Full Text] [Related]
9. [Proceedings: Rifampicin adverse effects in intermittent therapy]. Herrmann H, Eule H, Lau W, Kuhnert R, Fanter D, Kahlau U, Schönert E, Werner E. Z Erkr Atmungsorgane Folia Bronchol; 1973 Feb; 138(1):146-58. PubMed ID: 4491712 [No Abstract] [Full Text] [Related]
10. [Results of initial treatment of pulmonary tuberculosis using ethambutol, isonicotinic acid hydrazide and rifampicin]. Kesztele V, Niederkofler J. Wien Med Wochenschr; 1970 Jun 20; 120(25):473-5. PubMed ID: 5518004 [No Abstract] [Full Text] [Related]
11. Six-month isoniazid-rifampin treatment for pulmonary tuberculosis in children. Reis FJ, Bedran MB, Moura JA, Assis I, Rodrigues ME. Am Rev Respir Dis; 1990 Nov 20; 142(5):996-9. PubMed ID: 2240853 [Abstract] [Full Text] [Related]
12. Intermittent rifampicin treatment of tuberculosis. Riska N, Mattson K. Scand J Respir Dis Suppl; 1973 Nov 20; 84():140-4. PubMed ID: 4522069 [No Abstract] [Full Text] [Related]
13. [Clinical evaluation of Rifampicin in pulmonary tuberculosis. 2. A controlled trial on the clinical effects of chemotherapy with Rifampicin-INH-PAS and SM-INH-PAS for treatment of original cases of pulmonary tuberculosis]. Donomae I, Fujita S, Gomi J, Hibino S, Horai Z. Kekkaku; 1970 Aug 20; 45(8):257-62. PubMed ID: 4918166 [No Abstract] [Full Text] [Related]
14. [Controlled trial of isoniazid.rifampicin.ethambutol regimen and isoniazid.rifampicin.pyrazinamide regimen in the primary chemotherapy for pulmonary tuberculosis (author's transl)]. Kekkaku; 1980 Jan 20; 55(1):7-13. PubMed ID: 6988627 [No Abstract] [Full Text] [Related]
15. Controlled clinical evaluation of three intermittent regimens employing low-dosage schedules of rifampicin in original treatment of pulmonary tuberculosis. Preliminary data on effectiveness and side effects. Nitti V. Scand J Respir Dis Suppl; 1973 Jan 20; 84():180-5. PubMed ID: 4593266 [No Abstract] [Full Text] [Related]
16. Fibrinogen and antithrombin III blood levels fluctuations during isoniazid or isoniazid plus rifampicin administration. Farmakis M, Travlou O, Aroni S, Fertakis A. Arzneimittelforschung; 1992 Aug 20; 42(8):1041-4. PubMed ID: 1418078 [Abstract] [Full Text] [Related]